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Cell-lineage tracing has revealed a complex heterogeneity present in postnatal tissue and adult progenitors.
Chau et al. (2014) and Long et al. (2014) provide further evidence for this among adipocytes, and their findings
underscore the importance of cellular ontogeny not just for development but also for potential treatment of
disease.Origins matter. While this axiom may
be debatable on a global scale given
constantly changing geopolitical land-
scapes and regression of ethnocentric
thought, on the level of an individual or-
ganism, the importance of origin cannot
be ignored. Experiments in fate mapping
of embryonic tissue have been performed
for nearly a century, but in more recent
years, developments in transgenic tech-
niques and fluorescent peptide tracers
have allowed formore granularity with sin-
gle-cell resolution. Studies by Chau et al.
(2014) and Long et al. (2014) have em-
ployed these advances, and their findings
help to highlight the importance of cellular
ontogeny, not only from a developmental
perspective but also for tissue homeosta-
sis, development of disease, and tissue
repair/regeneration.
Given the rise in obesity and associated
metabolic disorders, considerable interest
in the developmental origins of adipose
tissue has developed. Of particular sig-
nificance has been the revelation of het-
erogeneity among fat, which may reflect
diversity in embryological origin (Billon
and Dani, 2012). In a recent report by
Chau et al. (2014), major ontogenetic dif-
ferences in visceral and subcutaneous
white adipose tissue were described, and
cell-lineage analysis based on Wilms’ tu-
morgene,Wt1, expression revealedsignif-
icant lateral plate mesoderm contribution
to development of visceral adipocytes.
This contrasts with the known contribution
to subcutaneous and brown adipocytes
from paraxial mesoderm and neural crest.
Importantly, however, Chau et al. (2014)
also noted intradepot heterogeneity
among visceral adipocyte precursors, as
Wt1 expression among preadipocytes
was not uniform.While preliminary studies900 Cell Metabolism 19, June 3, 2014 ª2014found this to manifest in variable numbers
of lipiddropletspercell,whether this trans-
lates to differences inmetabolic properties
and what implications this may have on
obesity and obesity-associated diseases
have yet to be fully elucidated.
Further level of detail into the cellular
heterogeneity of fat has now been pro-
vided by Long et al. (2014), who employed
a transcriptional profiling approach and
in vivo fate mapping to probe distinct
subsets of thermogenic adipocytes.While
two types of these specialized fat cells are
known to exist—classical brown fat and
beige fat found interspersed in various
white fat depots—studies have shown
distinct cellular ontogeny, which is likely
reflected in different behavior and func-
tion. Brown fat precursors arising from
paraxial mesoderm express Myf5/Pax7
indicative of a skeletal muscle lineage. In
contrast, Long et al. (2014) surprisingly
noted beige fat to be associated with
a constellation of markers classically
associated with smooth muscle. Lineage
tracing using Myh11, a selective marker
for smooth muscle cells, demonstrated a
significant proportion of UCP-1 positive
cells in inguinal fat to derive from mature
Myh11-expressing cells. These findings
provide an interesting context from which
to interpret crosstalk between perivascu-
lar adipocytes and vascular smooth mus-
cle. They also underscore the significance
of cellular origin, as these ontogenetic dif-
ferences likely contribute to observations
of preferential browning and baseline/
inducible thermogenic behavior in various
fat depots (Seale et al., 2011).
Heterogeneity and an appreciation
for cellular ontogeny, however, extend
far beyond that of adipose tissue, and
recapitulation of this theme can beElsevier Inc.found throughout multiple other systems.
Skin is constantly turned over, and the
epidermis is completely replaced every
28 days. Whether newly generated skin
is thin and hair bearing for the face and
scalp or thick and hairless for the palm
and sole is dependent on a complex inter-
play of disparate progenitor cells and their
positional/ontogenetic memory. In recent
years, new populations of stem cells
have been identified residing in the hair
follicle or interfollicular epidermis, and
studies have revealed a complex tempor-
ospatial interplay during states of health
and injury highlighting the diversity of
cells at work (Ghazizadeh and Taichman,
2001). Reports have shown some of this
may be regulated by maintenance of
HOX profiles, which in turn activate spe-
cific transcriptional programs dictating
epidermal differentiation patterns (Rinn
et al., 2008). In addition, fibroblast precur-
sors derived from mesenchymal stem
cells have been found to faithfully ex-
press position-specificHOX genes, which
reflect the embryonic segment fromwhich
they are derived. Unpublished work from
our own laboratory has also identified
heterogeneity among fibroblasts and has
shown distinct populations to directly
contribute to development of scars.
From the perspective of bone, distinct
embryologic derivation of osteoblasts
has also been found to impart variable
bone-forming potential and regenerative
capacity. Lineage-tracing studies have
demonstrated a neural crest origin for
frontal bone and paraxial mesoderm
contribution to parietal bone. Importantly,
this is reflected in origin-specific Wnt
and FGF-signaling differences, resulting
in superior intrinsic osteogenic potential
and tissue regeneration capacity among
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(Quarto et al., 2010.) Furthermore, hetero-
geneity among osteoprogenitors may
also have direct implications on healing,
as embryonic origin of skeletal stem cells
has been shown to determine progenitor
cell fate during bone repair (Leucht et al.,
2008). Lastly, as Chau et al. (2014) noted,
depot-specific differences in osteoblast
forming capacity was found among the
stromal vascular fraction from various fat
pads. This same observation has been
made from our own laboratory, and sifting
through heterogeneity of adipose-derived
stromal cells will be critical for future
efforts in bone tissue engineering.
Finally, understanding cellular ontogeny
may have direct implications on the treat-
ment of disease. For example, integrated
genomic studies have revealed medullo-
blastoma to be comprised of four distinct
molecular subsets with variable clinical
behavior. One of these subtypes, WNT,
has been shown to arise from cells of
the dorsal brainstem outside the cere-
bellum, which contrasts with other sub-
types arising from granule neuron pre-
cursor cells (Gibson et al., 2010). This
distinction has become important in that
proliferation of granule neuron precursorsmay be regulated by FGF and treatment of
medulloblastoma-bearing mice with this
growth factor markedly inhibits tumor ac-
tivity (Emmenegger et al., 2013). Thus,
future molecular targeting of tumors may
depend on an appreciation of where these
cells arise.
Origins matter, and not just from a
developmental perspective. Recognition
of cellular ontogeny provides a necessary
context to begin to address issues with
homeostasis, disease, and tissue repair.
In light of findings by Chau et al. (2014)
and Long et al. (2014), an appreciation
of origin may facilitate development of
more targeted therapeutics aimed at spe-
cific adipocytes for treatment of meta-
bolic syndrome. And given the heteroge-
neic complexity of postnatal tissue and
resident adult progenitor cells, compre-
hension of ontogenetic differences may
also yield new strategies for tumors such
as liposarcoma, healing of soft tissue
and bone, and treatment of a variety of
other disorders.REFERENCES
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